Sunder Biomedical Tech. Co., Ltd.

NT$6.97As of Sun 8 Nov 2026, 12:00 UTC

TPEx:4115Healthcare

Country Taiwan

PE (Fwd) —

TSR 4Y CAGR (21.13%)

Div yield —

ROE (2.12%)

Medical Instruments & Supplies

Beta (5Y) —

PE TTM —

TSR TTM (17.51%)

Mkt cap NT$418.2M

ROIC (1.66%)

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

NT$7.32

5.08%

117.83%

Price below Reference Value

TTM

FYE 31 Dec TWD

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

0.753

RevenueNT$B

—

1.054

0.770

0.767

0.753

0.694

(10.57%)

—

(1.74)

Revenue growth%

—

(26.90)

(0.44)

(1.74)

(7.95)

(1.74)

—

13.60

Gross margin%

—

13.34

10.12

18.53

13.60

13.40

13.47

—

(2.30)

Operating margin%

—

1.47

(4.86)

3.14

(2.30)

(2.70)

(0.41)

—

(2.16)

Net margin%

—

1.26

(4.30)

3.79

(2.16)

(2.51)

(0.45)

—

P/E ratio (avg)x

—

81.36

—

24.87

—

53.12

—

EV/EBITx

—

91.86

—

41.29

—

66.58

—

(1.88)

FCF yield (avg)%

—

2.82

(1.27)

1.38

(1.43)

(2.22)

0.05

—

(1.04)

FCF margin%

—

2.90

(1.80)

1.30

(1.04)

(1.34)

0.13

—

0.483

FCF / Net incomex

—

2.296

0.417

0.343

0.483

—

0.450

—

(1.66)

ROIC%

—

1.37

(3.31)

2.21

(1.66)

(1.79)

(0.14)

—

(2.12)

Return on equity%

—

1.68

(4.34)

3.85

(2.12)

(2.32)

(0.22)

—

(1.28)

Return on assets%

—

0.93

(2.36)

2.21

(1.28)

(1.38)

(0.17)

—

(0.27)

EPSNT$

—

0.22

(0.55)

0.48

(0.27)

(0.29)

47.82%

—

(155.92)

EPS growth%

—

(349.19)

187.69

(155.92)

(6.89)

(155.92)

—

12.63

Bookvalue per shNT$

—

13.16

12.26

12.95

12.63

12.34

(1.36%)

—

(0.13)

FCF per shareNT$

—

0.51

(0.23)

0.17

(0.13)

(0.15)

(42.86%)

—

Dividend per shNT$

—

Div yield (avg)%

—

Payout ratio%

—

60.00

Shares (diluted)M

—

60.06

60.00

60.05

60.00

◌60.00

(0.03%)

—

0.08

Buyback yield%

—

0.10

(0.08)

0.08

◌—

0.08

—

0.513

D/E ratiox

—

0.603

0.668

0.516

0.513

0.525

0.560

—

0.708

Enterprise valueNT$B

—

1.427

1.479

0.995

0.837

0.717

(16.27%)

—

132.2

LT debtNT$M

—

228.4

221.8

152.7

132.2

(16.65%)

—

Peers (US$12.63M)

Cap (US$)

Concord Medical Co.…

29.65M

11.55x

Perfect Medical…

29.46M

28.57x

Ttbio Corp.

25.78M

—

Cuprina Holdings…

12.61M

—

Capital

TTM

10Y

Leveragex

4.170

3.514

EBIT/Intx

(1.840)

(0.199)

Own earn%

—

Sh yield%

0.08

Owners

Insiders/Inst%

6.42

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

2/4

Revenue growth years

0/3

EPS growth years

1/3

Dividend streakyrs

Op margin range%

−5–3

$1 testx

—

Incr. ROIC%

—

Sunder Biomedical Tech. Co., Ltd. manufactures and sells medical devices. The company offers endoscopy vision set, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. fistula needle, I.V. administration, volume control I.V.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

NT$753.5M

(10.57%)

1.00×

Cost of revenue

NT$651.0M

(10.66%)

1.00×

Operating expenses

NT$119.8M

(1.39%)

1.34×

Asset mix

Trend

Other

92.21%

Cash and investments

7.79%

Reinvestment returns

No breakdown available